Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

S. Ceeraz; C. Hall; E. H. Choy; J. Spencer; V. M. Corrigall

doi:10.1111/cei.12161

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Cited By ~ 23

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

O11 Drug-Specific Risk and Associated Factors with Vasculitis-Like Events in Patients Exposed to Tumour Necrosis Factor Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/kew120.004 ◽

2016 ◽

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Associated Factors ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

British Society ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Biologics Register

Download Full-text

Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs

Clinical Rheumatology ◽

10.1007/s10067-017-3961-6 ◽

2018 ◽

Vol 37 (4) ◽

pp. 909-916 ◽

Cited By ~ 9

Author(s):

Gerard A. Rongen ◽

Iris van Ingen ◽

Marc Kok ◽

Harald Vonkeman ◽

Matthijs Janssen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108991.565450 ◽

2008 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Joint Damage ◽

Tumour Necrosis Factor Inhibitor ◽

Inadequate Response ◽

Structural Joint ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

248 Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/key075.472 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Jonathan Massey ◽

Darren Plant ◽

Kimme Hyrich ◽

Ann W Morgan ◽

Anthony G Wilson ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Association Study ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Genome Wide Association Study ◽

Tumour Necrosis Factor Inhibitor ◽

Genome Wide Association ◽

Genome Wide ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-201319 ◽

2012 ◽

Vol 72 (1) ◽

pp. 57-63 ◽

Cited By ~ 23

Author(s):

Lykke Midtbøll Ørnbjerg ◽

Mikkel Østergaard ◽

Pernille Bøyesen ◽

Niels Steen Krogh ◽

Anja Thormann ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Radiographic Progression ◽

Tumour Necrosis Factor Inhibitor ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Download Full-text

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kes184 ◽

2012 ◽

Vol 51 (11) ◽

pp. 2020-2026 ◽

Cited By ~ 54

Author(s):

H. Canhao ◽

A. M. Rodrigues ◽

A. F. Mourao ◽

F. Martins ◽

M. J. Santos ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Comparative Effectiveness ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitor ◽

Predictors Of Response ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology ◽

10.1080/03009742.2020.1716992 ◽

2020 ◽

Vol 49 (3) ◽

pp. 253-255

Author(s):

H Matsuoka ◽

D Kabata ◽

A Taura ◽

T Matsui ◽

K Takahi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Single Nucleotide Polymorphism ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Japanese Patients ◽

Tumour Necrosis Factor Inhibitor ◽

Nucleotide Polymorphism ◽

Single Nucleotide ◽

Factor Inhibitor ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort

Rheumatology ◽

10.1093/rheumatology/keu255 ◽

2014 ◽

Vol 54 (1) ◽

pp. 152-156 ◽

Cited By ~ 23

Author(s):

D. Wallis ◽

A. Thavaneswaran ◽

N. Haroon ◽

R. Ayearst ◽

R. D. Inman

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Axial Spondyloarthritis ◽

Infection Risk ◽

Tumour Necrosis Factor Inhibitor ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

Observational Cohort ◽

Necrosis Factor

Download Full-text